Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine to Determine the Mechanism of PVCs
NCT03218137Phase 4Recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- Feb 2017
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of adenosine in Premature ventricular contraction (PVC), sponsored by Weill Cornell Medicine. Started Feb 2017; status: recruiting.
02
Drugs
adenosine
03
Conditions
Premature ventricular contraction (PVC)
Beyond the preview
Go deeper on NCT03218137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03218137.